#StayInformed: February 2024 PubMed curation

  • Omatsu et al, Allergol Int 2024
    ➜ PMID: 38310042. – DOI: 10.1016/j.alit.2024.01.008
    An interesting study from Japan shows that AD is very significantly associated with the incidence of HSV keratitis, and that preexisting AD blepharitis is an important contributing factor.
    This paper is important in the context of real or supposed AD co-morbidities where ophthalmologic comorbidities are generally not adequately considered except for dupilumab side effects.
  • Wilkie et al, JACI 2024
    ➜ PMID: 38185418. – DOI: 10.1016/j.jaci.2023.12.020
    Autosomal recessive hyper IGE syndrome with DOCK8 deficiency which is frequently associated with an AD phenotype was studied by the group of Geha (Boston) and, interestingly in the context of regulatory T cell dysfunction, shows a driving effect of S. aureus on AD lesions independently of a barrier defect.

  • Kline et al, PNAS 2024
    ➜ PMID: 38289950. – DOI: 10.1073/pnas.2309243121
    Coincidentally a recent PNAS paper shows on a mouse model of AD that S.aureus has a direct effect on the local recruitment of IL 17 producing eosinophils.
  • Avallone et al, JAAD, 2024
    ➜ PMID: 38199282. – DOI: 10.1016/j.jaad.2024.01.004
    Our Italian colleagues coined aptly the new term of JAKne for acneiform eruptions following JAK inhibitors treatment.
  • Suzuki et al, IJMS, 2024
    ➜ PMID: 38203432. – PMCID: PMC10779290. – DOI: 10.3390/ijms25010265
    The discussion phenotypes/endotypes for AD has been fueled by many studies where poorly defined phenotypes were studied for blood or skin biomarkers. Tokura and his team present a comprehensive review of the situation with several relevant remarks.